AbbVie (ABBV) free cash flow

Free cash flow · fiscal 2025
$17.82B

AbbVie (ABBV) generated free cash flow of $17.82B in fiscal 2025 (the year ended December 31, 2025). That is 0.1% lower than the $17.83B of fiscal 2024. Figures as of 18 Nov 2026, 12:16 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$17.82B
Change on fiscal 2024
−0.1%
Growth, 5 years
+1.2% a year
Growth, 10 years
+9.8% a year
Highest on record
$24.25Bfiscal 2022
Lowest on record
$2.94Bfiscal 2014
Fiscal years on record
152011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

AbbVie free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow grew at a compound 1.2% a year; over ten years the rate was 9.8% a year. Across the 15 fiscal years on record (2011–2025), the highest was $24.25B in fiscal 2022 and the lowest $2.94B in fiscal 2014.

History · 15 fiscal years

Free cash flow by fiscal year

AbbVie free cash flow, year by year

AbbVie (ABBV) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$17.82B 0.1% down
2024$17.83B 19.2% down
2023$22.06B 9.0% down
2022$24.25B 10.3% up
2021$21.99B 31.0% up
2020$16.79B 31.5% up
2019$12.77B 0.1% down
2018$12.79B 35.6% up
2017$9.43B 43.7% up
2016$6.56B 6.3% down
2015$7.00B 138.4% up
2014$2.94B 49.2% down
2013$5.78B 3.9% down
2012$6.01B 2.1% up
2011$5.89B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of AbbVie and comparable companies
CompanyFree cash flowFiscal year
Eli Lilly LLY$5.96B2025
Johnson & Johnson JNJ$19.31B2025
AbbVie ABBV$17.82B2025
Merck & Co MRK$12.36B2025
UnitedHealth Group UNH$16.08B2025
Novartis NVS$15.24B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ABBV

AbbVie, figure by figure

AbbVie (ABBV) overview: price, valuation and scorecardAll health care companies by market value

AbbVie free cash flow: questions and answers

What is AbbVie's free cash flow?

AbbVie (ABBV) generated free cash flow of $17.82B in fiscal 2025 (the year ended December 31, 2025). That is 0.1% lower than the $17.83B of fiscal 2024.

What is the growth rate of AbbVie's free cash flow?

Over the five fiscal years to 2025 free cash flow grew at a compound 1.2% a year; over ten years the rate was 9.8% a year.

What are the highest and lowest free cash flow figures on record for AbbVie?

Across the 15 fiscal years on record (2011–2025), the highest was $24.25B in fiscal 2022 and the lowest $2.94B in fiscal 2014.

How is AbbVie's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For AbbVie it is on record here for 15 fiscal years, 2011 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “AbbVie (ABBV) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/ABBV/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.